PHILADELPHIA, PA (May 13, 2009)-A new advocacy group, The Patient Recruitment Organization (PRO) Steering Committee, has been formed to represent the international patient recruitment and retention industry. The committee's goal is to identify and address ongoing issues to help strengthen this niche industry. The group convened recently in Philadelphia to discuss core issues impacting patient recruitment organizations.
The PRO Steering Committee comprises a select delegation of patient recruitment leaders. The first summit was held April 16 at the Westin Philadelphia and drew executives from top patient recruitment organizations, including D. Anderson Company (DAC), Fleishman-Hillard Clinical Trials Division, Healthcare Communications Group, On The Scene Productions, Inc., (Pi) Patient interaction, RxTrials, and The Patient Recruiting Agency£ (TPRA). The event was co-hosted by Dallas, Texas-based DAC and Austin, Texas-based TPRA.
"Our discussions centered on several market trends which underscore the need for greater collaboration and cooperation among PROs," said Diana Anderson, Ph.D., president and CEO of DAC.
TPRA President Lance Nickens added, "It is exciting that competitors can come together in an effort to uplift the industry. By uniting in this way and jointly participating in education and standardization, we can influence everything from public perception to public policy."
The committee identified five areas of interest for advancing the patient recruitment and retention industry, namely, whether to form a professional trade organization; risk sharing; identifying industry trends; expanding globally; and improving how patient recruitment organizations work with stakeholders, including pharmaceutical and biotechnology companies, contract research organizations and clinical trial sites.
The PRO Steering Committee's next steps include broadening participation in the committee to other patient recruitment organizations and developing a position paper summarizing their strategies. The group will hold monthly teleconferences and re-convene in person within 12 months.
About The Patient Recruitment Organization (PRO) Steering Committee:
The PRO Steering Committee is an ad hoc group of professionals who lead patient recruitment organizations. The goal of the committee is to work together to address issues and trends that impact the provision of their patient recruitment and retention services globally.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.